529 related articles for article (PubMed ID: 32698843)
21. Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.
Tyagi N; Hipp E; Cloutier M; Charas T; Fontenla S; Mechalakos J; Hunt M; Zelefsky M
J Appl Clin Med Phys; 2019 Jul; 20(7):121-127. PubMed ID: 31206236
[TBL] [Abstract][Full Text] [Related]
22. Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.
Sawayanagi S; Yamashita H; Ogita M; Takenaka R; Nozawa Y; Watanabe Y; Imae T; Abe O
Radiat Oncol; 2022 Feb; 17(1):41. PubMed ID: 35197092
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
[TBL] [Abstract][Full Text] [Related]
25. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note.
Jmour O; Benna M; Champagnol P; Ben Mrad M; Hamrouni A; Obeid L; Lahmamssi C; Bousarsar A; Vial N; Rehailia-Blanchard A; Sotton S; Lan M; Langrand-Escure J; Vallard A; Magné N
Radiat Oncol; 2020 Apr; 15(1):85. PubMed ID: 32307017
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a rectal spacer with prostate SABR-first UK experience.
King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
[TBL] [Abstract][Full Text] [Related]
28. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
31. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience.
Ozyigit G; Hurmuz P; Akinci D; Esen SCB; Yilmaz MT; Akdogan B; Akyol FH
Cancer Radiother; 2020 Dec; 24(8):805-811. PubMed ID: 32565071
[TBL] [Abstract][Full Text] [Related]
33. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
[TBL] [Abstract][Full Text] [Related]
34. Organ motion in linac-based SBRT for glottic cancer.
Perillo A; Landoni V; Farneti A; Sanguineti G
Radiat Oncol; 2021 Jun; 16(1):106. PubMed ID: 34118965
[TBL] [Abstract][Full Text] [Related]
35. Relationship between hydrogel spacer distribution and dosimetric parameters in linear-accelerator-based stereotactic body radiotherapy for prostate cancer.
Ohira S; Yamashita H; Minamitani M; Sawayanagi S; Ogita M; Imae T; Katano A; Nozawa Y; Ohta T; Nawa K; Nishio T; Koizumi M; Nakagawa K
J Appl Clin Med Phys; 2024 Jun; 25(6):e14294. PubMed ID: 38319652
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison.
Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K
Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956
[TBL] [Abstract][Full Text] [Related]
37. Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
Leiker AJ; Desai NB; Folkert MR
Future Oncol; 2018 Nov; 14(26):2773-2788. PubMed ID: 29939069
[TBL] [Abstract][Full Text] [Related]
38. The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).
Sturt P; Suh YE; Khoo V
Med Dosim; 2022 Summer; 47(2):173-176. PubMed ID: 35277316
[TBL] [Abstract][Full Text] [Related]
39. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
[TBL] [Abstract][Full Text] [Related]
40. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
